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Introduction
Integrins are cell adhesion receptors that transmit bidirectional signals across the plasma membrane and link the extracellular environment to the actin cytoskeleton (Hynes, 2002) . All inte grins are noncovalently linked heterodimeric molecules consist ing of one  and one  subunit, in which both subunits are required to create a functional binding site at the membrane distal part of the cell surface receptor for specific extracellular ligands. Compared with other cell adhesion receptor classes, integrin's ligand recognition mechanism is highly unique in three aspects. First, the ligand recognition specificity of each integrin heterodimer is determined combinatorially, in that both the  and the  subunits contribute to the selective ligand binding of the resultant heterodimeric receptor, and even the same  (or ) subunit will bind different ligands when paired with a different  (or ) subunit (Hynes, 2002) . Second, in contrast to other divalent cationdependent cell adhesion molecules such as cadherins in which metals do not directly bridge two mole cules across the cell-cell junction (Patel et al., 2006) , the core mechanism of integrin-ligand recognition involves a direct co ordination bond between an Mg 2+ bound on the integrin (called the metal ion-dependent adhesion site [MIDAS] ) and a carboxy late oxygen from the ligand. Lastly, the ligandbinding affinity of integrins can be modulated allosterically via conformational changes that take place outside the binding pocket (Carman and Springer, 2003) . The determination of crystal structures of 3 integrin ectodomain fragments have contributed enormously to our understanding of the integrin-ligand interactions (Xiong et al., 2001 (Xiong et al., , 2002 (Xiong et al., , 2009 Xiao et al., 2004; Springer et al., 2008; Zhu et al., 2008 Zhu et al., , 2010 . Specifically, the structures of V3 and IIb3 integrins in complex with their cognate peptide ligands represented by the ArgGlyAsp (RGD) sequence revealed how the small tripeptide portion is specifically recognized by integrins using a small binding cleft at the subunit interface and how the ligand binding is associated with the transition from the closed or lowaffinity conformation to the open or highaffinity conformation of integrin. However, there remain important unanswered questions. For example, lack of an atomic resolution structure of integrin in complex with a protein ligand, which usually bears both a core binding motif such as RGD and a secondary synergy site, precludes the complete understanding I ntegrin 51 is a major cellular receptor for the extracellular matrix protein fibronectin and plays a fundamental role during mammalian development. A crystal structure of the 51 integrin headpiece fragment bound by an allosteric inhibitory antibody was determined at a 2.9-Å resolution both in the absence and presence of a ligand peptide containing the Arg-Gly-Asp (RGD) sequence. The antibody-bound 1 chain accommodated the RGD ligand with very limited structural changes, which may represent the initial step of cell adhesion mediated by nonactivated integrins. Furthermore, a molecular dynamics simulation pointed to an important role for Ca 2+ in the conformational coupling between the ligand-binding site and the rest of the molecule. The RGD-binding pocket is situated at the center of a trenchlike exposed surface on the top face of 51 devoid of glycosylation sites. The structure also enabled the precise prediction of the acceptor residue for the auxiliary synergy site of fibronectin on the 5 subunit, which was experimentally confirmed by mutagenesis and kinetic binding assays.
Crystal structure of 51 integrin ectodomain: Atomic details of the fibronectin receptor
The allosteric inhibitory antibody SG/19 makes extensive interactions with the long loop between  strands X and A (fol lowing the strand nomenclature by Xiong et al. [2001] ) of 1 hybrid domain using its antigencombining sites (Fig. 1 B) . The speciesspecific Thr82 that had been identified as the epitope for SG/19 was in fact deeply inserted into the pocket formed by complementaritydetermining region (CDR) loops H1, H2, H3, and L3. Furthermore, SG/19 also interacts with A domain res idues N151, R154, and R155 using its L2 loop outside the CDR core, anchoring the lower half of the 1 helix of A domain. Because of this twosided interaction, the H3 loop is wedged between A and hybrid domains and prevents the outward swing of the hybrid domain. This resulted in the closed head piece conformation with the tucked hybrid domain, similar to the ligandunbound, lowaffinity form of the 3 integrins. The similarity in the overall conformation can readily be appreciated upon structural superposition of the 51 headpiece onto the closed v3 (3IJE, 1.92Å rootmeansquare deviation [RMSD] of the basis for the physiological binding events. Also, two different conformations of 3 integrin were found in the ligand bound state, leading to a controversy over the structural path way that leads to the physiological activation/ligand binding for integrins. Another important issue is whether the same ligand recognition and affinity modulation mechanisms apply for integrins outside the 3 class. It is particularly important to obtain structural information about 1 integrins because they constitute the largest and probably the most ancient inte grin subclass (Brower et al., 1997) and are fundamentally in volved in mammalian development.
We report herein the crystal structure of a ligandbinding fragment of human 51 integrin, a prototypic integrin that functions as an RGDdependent fibronectin receptor. The struc ture, solved as a complex with a Fab fragment of the anti-1 inhibitory antibody SG/19, revealed high similarity to the ligand unbound form of V3 and IIb3 integrins. Surprisingly, the RGD peptide can be introduced into the binding pocket by soaking, without causing any conformational change in integrin except for an 1Å shift of one residue and the dissociation of Ca 2+ from the adjacent to the MIDAS (ADMIDAS). Docking simulations and structurebased mutagenesis identified a single 5 residue responsible for the strong preference of 51 for fibronectin, establishing a basis for the combinatorial roles played by each subunit during the specific recognition of protein ligands.
Results
Despite extensive efforts, our initial attempts to crystallize the fulllength 51 ectodomain fragment were unsuccessful. When we imaged various recombinant soluble integrins using negativestain EM, we realized that the conformation of 51 was highly heterogeneous as a result of its flexible lower half (unpublished data), whereas fulllength V3 integrin showed uniformly compact bent conformation reminiscent of the crys tal structure (Takagi et al., 2002) . We reasoned that this con formational heterogeneity was to blame for the difficulty in crystallizing fulllength 51 and thus focused on the truncated fragment devoid of the lower half (referred to hereafter as the headpiece fragment). A previous EM study showed that SG/19 binds at the junction between the A and the hybrid domains of 1 subunit, thereby fixing the conformation of the hybrid domain, which is highly mobile in the context of the truncated fragment (Luo et al., 2004) . We took advantage of this phenom enon to crystallize the 51 integrin headpiece fragment by making a complex with SG/19 Fab in the presence of physio logical concentrations of Mg 2+ and Ca
2+
. The structure, refined at a 2.9Å resolution, contained all of the domains present in the constructs, including the propeller and thigh domains of 5 subunit, the plexin/semaphorin/integrin (PSI), hybrid and A domains of 1, and the SG/19 Fab (Fig. 1 A; see also a rocking video in Video 1). Two 51-Fab complexes were contained in one crystallographic asymmetric unit and were essentially identical except for minor differences in the interdomain angles at the lower half of the molecule (Fig. S1 ). Therefore, we de scribe the structure of one complex (chains A, B, E, and F) in the following discussion. fulllength 51 integrin (Luo et al., 2004) . We confirmed this finding in surface plasmon resonance assays using the truncated headpiece fragment of 51 (Fig. 3) . Binding of the unclasped 51 headpiece fragment to the fibronectin ligand (Fig. 3 , solid line) was greatly reduced but not completely abolished when bound by SG/19 (Fig. 3 , dotted line), whereas complete inhibi tion was achieved by anti-5 direct blocking antibody 16 (Fig. 3 , gray line). This suggests that the SG/19bound 51 integrin may become ligand occupied in the presence of a highconcentration ligand. We also confirmed that the headpiece fragment used in this study was capable of binding ligand in the divalent cation condition used in the crystallization (i.e., 1 mM Ca 2+ and 1 mM Mg 2+ ; Fig. 3, inset) , although the binding was much weaker than that in the presence of Mn 2+ . In line with the aforementioned expectation, soaking of the SG/19-51 complex crystal in a solution containing 1 mM hexapeptide GRGDNP resulted in an appearance of electron density above the MIDAS Mg 2+ , which we interpret as an RGD tripeptide segment (Fig. 2 B and Video 3). As the electron den sity of the ligand was weaker than the integrin part, we suspect that the occupancy of the peptide was not 100%, and the resul tant structure, refined at 2.9 Å, may represent the mean of ligandbound and unbound forms. Nevertheless, overall struc ture of the RGDbound 51 was very similar to that of ligand free integrin ( Fig. S2 and Video 4), which is consistent with the fact that the soaking did not change the diffraction quality of the crystal, nor did it affect the unit cell dimensions (Table 1 ). In the binding pocket, the Arg side chain makes hydrogen bonds with 5 residues Q221 and D227, and the Asp carboxylate directly coordinates the 1 MIDAS Mg 2+ , recapitulating the RGDbinding mode found in 3 integrins (Fig. 2 C) . In the V3-RGD complex structure (Xiong et al., 2002) , the Arg of RGD is hydrogen bonded to V D218 from the side, whereas in the IIb3-RGD complex, it is hydrogen bonded to IIb D224 head on (Fig. 2 C; Springer et al., 2008) . The Arg recognition for 864 C atoms) and IIb3 (3FCS, 1.52Å RMSD for 820 C atoms; Fig. 1 C) .
The three metalbinding sites found in 3 integrin were also present in 1, and we could see strong electron density at all sites ( Fig. 2 A and Video 2), indicating that they were occupied. Based on the coordination geometries and similarity to the previously determined structures of 3 integrins, we as signed Mg 2+ to the MIDAS and Ca 2+ to the two flanking sites, the ligandassociated metalbinding site (LIMBS; also called SyMBS) and ADMIDAS. The correctness of the metal assignments was also supported by an experiment using a crystal treated with Mg 2+ and EGTA, in which electron density for MIDAS remained unchanged, whereas that of ADMIDAS disappeared (unpub lished data). Density for LIMBS remained after this treatment, but the completely buried nature of this ion may have prevented the access of EGTA. The coordination environment for MIDAS and ADMIDAS ions in the current complex was essentially identical to that of ligandfree 3 (Fig. 1 C) . Therefore, binding of SG/19 not only induced the overall closed conformation of the headpiece (i.e., tucked hybrid domain) but also stabilized the lowaffinity MIDAS configuration.
A previous kinetic study indicated that SG/19 attenuates, but not abolishes, the ligandbinding capability of Mn the 1 subunit (Lahti et al., 2011) . In addition to the change in MIDAS configuration, there was another critical change in duced by RGD binding; the electron density corresponding to the ADMIDAS Ca 2+ was diminished in the RGDsoaked crystal (Figs. 2 B and S3 and Video 3), whereas that of LIMBS, MIDAS, and all other metals bound to the 5 subunit remained unchanged. This ADMIDASspecific Ca 2+ discharge seems inevitable be cause the two A residues that shifted most upon RGD binding, S134 and A342 (Fig. 4 A) , provided their backbone carbonyl to ADMIDAS coordination.
Very limited but characteristic changes in the 1 structure upon RGD binding prompted us to perform molecular dynam ics (MD) simulations to see whether these changes can be repro duced in silico. To focus on the local environment surrounding the ligandbinding pocket and the metals, only the region within 20 Å from the Ser132 was subjected to the calculation (Fig. 5 A) . In this condition, residues that are anchored by SG/19 were lo cated outside the simulated region, in effect mimicking the conformational freezing by SG/19. First, 10 independent MD simulations (40 nanoseconds each) were performed on the ligandunbound structure in which all the metal sites were occupied. The coordination environment of ADMIDAS remained largely undisturbed, and the Ca 2+ moved from its original posi tion in only 1 out of 10 simulations (Fig. 5 B, top) . We then per formed another set of simulations on the same structure after manually placing the RGD peptide at the binding pocket above the MIDAS Mg 2+ to mimic the very first step of the ligand en counter. In this condition, Ca 2+ at the ADMIDAS site became mobile and was expelled from the site in 5 out of 10 simulations (Fig. 5 [B and C] and Video 5). In contrast, both the MIDAS and LIMBS metals were highly stable and did not show major displacement from the original position. During the time frame of the simulation, the Ca 2+ did not completely diffuse away from the site but remained attached to integrin through hydrogen mode seen in 51 is a mixture of these, with both sideon (D227) and headon (Q221) hydrogen bonds present. Sequence alignment around this region suggests that 8, another RGD dependent integrin  subunit, has the sideon residue only (i.e., D225) and thus resembles V (Fig. 2 D) . As 5 is predicted to be the most ancient among the four (Hynes and Zhao, 2000) , the headon residue may have been lost during evolution to yield V and 8 and then reappeared in IIb with a concomitant loss of the sideon residue. In any case, the basic strategy for RGD recognition, in which the extended tripeptide portion is held by a twopoint anchor situated at the wellshaped binding pocket at the subunit interface, seems to be shared among all integrins, as predicted earlier (Takagi, 2007) .
The structure of RGDbound 51 was remarkably simi lar to that of the unliganded one, showing an RMSD of merely 0.27 Å for all C atoms (Fig. S2) . In V3 and IIb3 inte grins, binding of RGD or related ligands is accompanied by rear rangements of 1 and 7 helices and nearby segments in the A domain, converting the MIDAS configuration to a high affinity state that is characterized by a direct coordination of the last Ser residue in the conserved DXSXS motif to Mg 2+ (Figs. 4 B and S3; Xiong et al., 2002; Springer et al., 2008) . In 51, such structural rearrangements are largely prohibited by the bound SG/19, resulting in a surprisingly small RMSD of 0.19 Å between A domains of unliganded and RGDbound forms (Fig. 4 A) . Nevertheless, Ser134 moves 1 Å toward MIDAS to directly coordinate Mg 2+ , resulting in the high MIDAS con figuration (Figs. 4 A and S3) . This indicates that the direct coordination of the ligand carboxylate and the Ser hydroxyl to MIDAS Mg 2+ is internally coupled and can be accomplished even in the absence of the coordinated movements of the 1 and 7 helices. Similar rearrangement in the MIDAS coordination chemistry unaccompanied by 1 and 7 helix movements dur ing activation has been recently reported for the A domain of toward MIDAS, which is in agreement with the conformational shift that occurred during the RGD soaking experiment. Fur thermore, the failure of MD to reproduce the switch from the bonds with D137 and D138, causing a large disturbance in the conformation of the 11 loop containing these residues (and S134). To follow the complete dissociation process of Ca 2+ , much longer simulation (greater than a microsecond) and a more rigorous force field would be required. Therefore, the MD result is largely consistent with the ADMIDASspecific metal discharge upon ligand binding, which was observed in the crys tal of SG/19bound lowaffinity 51. Next, we focused on the movement of S134. Unlike in the crystal, significant movement of S134 toward Mg 2+ was not observed in the RGDbound structure, and the bond remained a watermediated indirect coordination with a mean distance of 4.48 Å (Figs. 5 D [+RGD] and S4 and Video 6). In the absence of the RGD ligand, how ever, the loop harboring S134 exhibited a high degree of mobil ity, and S134 tended to move away from the Mg we conclude that Asp154 of 5 and Arg1379 of fibronectin constitute the major interacting pair, as predicted from the docking simulation.
Discussion
1 integrins constitute the largest integrin subfamily and recog nize a wide range of ligands depending on the partner  subunit. 51 was one of the first integrin heterodimers to be identified, and its function as a fibronectin receptor has been studied exten sively (Tamkun et al., 1986) . Especially, the discovery of the site on fibronectin important for binding 51 integrin (syn ergy site) has set the basis for our general understanding of the integrin-ligand recognition mechanism, in which the combina tion of a core interaction (e.g., RGD site) with a secondary inter action (e.g., synergy site) ensures both high affinity and specificity (Obara et al., 1988; Aota et al., 1994) . It is known that R1379 makes the greatest contribution to the synergy effect on the indirect to direct coordination of S134 suggests that the high affinity MIDAS configuration may not necessarily be ligand induced but could be ligand stabilized.
The structure of the aforementioned RGD-51 com plex can be used to simulate how the protein ligand (i.e., fibro nectin) binds to integrin. As shown in Fig. 6 , the RGDbinding pocket is surrounded by several Nglycan chains, leaving a trenchlike exposed surface along the subunit interface. This re sults in a limited choice of docking orientation when the elon gated fibronectin molecule tries to make close contact. Simple docking of 30 nuclear magnetic resonance structures of core integrinbinding fibronectin fragments (Fn910) onto 51 using the RGD segment as a guide resulted in only a handful of com plex models compatible with both structures. Fig. 6 shows one of the most successful models, in which the Fn9 module ap proaches the 5 subunit. In this model, the residue known to be most important for the synergy activity of the fibronectin (Arg1379) is pointing toward the negatively charged surface created by Glu81, Glu124, and Asp154 of 5, which is likely to constitute the basis for the synergy effects. We individually mutated these residues to Ala and prepared recombinant solu ble 51 ectodomain fragments carrying these mutations and tested their ability to bind fibronectin. In the solidphase bind ing assay, wildtype (WT) integrin 51 showed 10-50fold lower affinity toward the fibronectin fragment lacking the three synergy residues (R1374, P1376, and R1379) than the WT fibro nectin fragment (Fig. 7 A, top left graph; Takagi et al., 2003) . This synergy site dependency was also observed with mutant 51 carrying either the E81A or the E124A mutation (Fig. 7 A) , indicating that these residues are not required for the synergy site recognition. In contrast, the D154A integrin mutant could no longer distinguish between WT and mutant fibronectin (Fig. 7 A, bottom right graph), suggesting the critical importance of this residue for the synergy effect. Similar results were obtained in the surface plasmon resonance analysis using immobilized Fn7-10 and solutionphase integrin (Fig. 7 B) . As a single resi due mutant of Fn7-10 (i.e., R1379A) was used in this experi ment instead of the triple mutant used in the solidphase assay, Figure 6 . A model of the Fn9-10-51 complex. The no. 10 molecule from the mouse Fn9-10 fragment nuclear magnetic resonance structures (Protein Data Bank accession no. 2MFN) docked onto the 51 using the bound RGD peptide (green stick model) as a guide is shown as a magenta ribbon model, with the Arg1379 side chain highlighted. Carbohydrate moieties are shown by modeling GlcNAc 2 Man 5 residues (space-filling model) at the tip of Asn residues. 5 and 1 chains are surface rendered in wheat and gray, respectively, except for the three acidic residues (red) and MIDAS Mg 2+ (blue). The trenchlike exposed surface is marked by black dotted lines. Figure 7 . Determination of the synergy site acceptor residue on 5 subunit. (A) Solid-phase equilibrium binding using immobilized full-length 51 ectodomain and solution-phase biotinylated Fn7-10. Binding experiments with WT (closed squares) or R1374A/P1376A/R1379A mutant (open circles) Fn7-10 fragments to four different 51 preparations were performed, and data from one representative of three independent experiments are shown. (B) Effect of synergy residue mutations on the binding kinetics studied by surface plasmon resonance analysis. WT (solid lines) and R1379A mutant (dotted lines) biotinylated Fn7-10 were immobilized separately onto a streptavidin-coated chip (1,000 resonance units [RU] ). The surface was infused for 60 s with either WT (left) or D154A-purified (right) full-length recombinant 51 integrin at 20 nM in a running buffer containing 1 mM Mn 2+ , and the dissociation phase was followed for 100 s. The data are from a single representative experiment out of three repeats. Mould et al. (2002) , if the 1 helix is not frustrated by SG/19. As this inward movement of the 1 helix was observed in all ligandbound 3 structures reported so far regardless of the conformation of the hybrid domain, it is likely that the SG/19 exerts its inhibitory action primarily through the 1 helix rather than the hybrid domain. In fact, epitopes for a series of antichicken 1 antibodies with functionblocking activity have been mapped exactly to this region (Shih et al., 1997) , suggest ing an intimate relationship between the ligand binding and the conformational freedom of the 1 helix. Although there is no anti-human 1 antibody mapped to this region as a result of the sequence conservation between human and mouse 1, there are many functionmodulating (i.e., inhibitory and activating) anti bodies mapped to the neighboring 2 helix (Takada and Puzon, 1993; Luo et al., 2004) . These antibodies are likely to recognize residues in 1 helix as well, just like in the case of SG/19. There fore, the segregation of epitopes for many functionmodulating antibodies in this region suggests that this region exists in at least two alternative conformations (i.e., high and lowaffinity forms) and that each antibody affects the ligandbinding ability depending on the conformer it stabilizes.
Highresolution structures of the IIb3 headpiece re vealed that the 3 MIDAS always assumes octahedral geome try, with the top axial coordination site reserved for a water or ligand carboxylate. The configuration of the MIDAS metal can be grouped into two types that differ by only one coordi nation site, one with a direct coordination from the side chain of the last Ser residue of the DXSXS motif (MIDAS high con figuration) and the other with the same bond replaced with a watermediated indirect coordination (MIDAS low configuration; Fig. S3 ). In 3 integrins, binding of a ligand or a ligandmimetic analog is tightly coupled with the MIDAS high configuration (Zhu et al., 2010) . Here, we showed that the same coupling exists in 1 integrin. Our MD simulation data also hinted an energetic linkage between the two coordination bonds. Fur ther quantum mechanical calculations would reveal the pre cise mechanism of the coupling.
As we used the allosteric inhibitory antibody SG/19 to minimize the interdomain flexibility intrinsic to 51 integrin to facilitate crystallization, the RGDbound 51 structure we obtained must be regarded as somewhat artificial. Nevertheless, this procedure may have served to visualize a structural state corresponding to the very first step of physiological ligand bind ing by integrins on the resting cell surface. Thus, a ligand can approach the resting integrin with MIDAS low to produce transient ligand docking. The ligandbound MIDAS low would quickly be converted to MIDAS high by pulling the 11 loop (and the Ser134 therein) closer, together with the Ca 2+ loaded ADMIDAS. In our crystal structure, however, only the S134 (and the fol lowing two residues) are forced to move toward Mg 2+ to fulfill the requirement for MIDAS high configuration because fullloop movement is prohibited by SG/19 anchorage of the C terminus of the 1 helix. At the same time, this movement destabilized the coordination environment of the ADMIDAS, resulting in the release of Ca 2+ . Although the physiological importance of ADMIDAS in integrin function is well appreciated, the exact role played by fibronectin side (Redick et al., 2000) . Through structureguided mutation experiments, we have now successfully identified the specific residue (Asp154) that distinguishes 5 from other  subunits and results in its strong preference for fibronectin over other RGD ligands.
Binding between 51 and fibronectin has been exten sively studied through biochemical, immunochemical, and cell biological approaches (Humphries, 2000) , and most of those re sults can be rationalized by the current structure. For example, the epitope for the anti-5 antibody mAb 16 has been mapped to E116/L118 that sits next to the RGDbinding pocket, which is in line with the strong and direct functionblocking ability of this antibody (Burrows et al., 1999) . Leu212, the epitope residue for another functionblocking antibody P1D6, is located adjacent to D154, explaining why this antibody preferentially blocks syn ergy site interaction (Mould et al., 1997) . Ala mutation of I210 was reported to severely compromise the interaction with the synergy region (Mould et al., 2003b) . As the side chain of I210 makes van der Waals contact with D154 to orient its side chain outward, the I210A mutation may indirectly affect the synergy site binding by partially burying the D154 carboxylate. Also, it has been reported that W157 is responsible for the 5 subunit's preference for the RGDGW peptide . The side chain of W157 rises on one side of the RGDbinding pocket, and it is likely that the bound RGDGW peptide makes a reverse turn at the second Gly to allow the TrpTrp ring packing. In addition to providing these fine residuewise structural in sights into the ligand recognition mechanism, the structure offers a unique view of how the ligandbinding specificity might be regulated by sugar chains. In contrast to the 3 chain, which is de void of Nglycosylation sites on the top face of the A domain, 1 possesses two conserved Nglycosylation sites near the ligand binding site (Fig. 6 ). These glycans, together with two more gly cans attached to 5, would occupy considerable space because of their conformational flexibility. Such a canopy may function to selectively capture only the ligands that have the RGD se quence at an apex of a protruding loop (Leahy et al., 1996; Copié et al., 1998) or to restrict the preferential orientation of transient docking of fibrillar ligands so that the RGD site along the fiber can be scanned efficiently. As differences in the glycosylation state of 51 on the cell surface have been reported to affect the biological function of the receptor (Seales et al., 2005; Isaji et al., 2006 Isaji et al., , 2009 , it would be valuable to test these possibilities in a cellbased system.
A previous EM study predicted that SG/19 exerts its in hibitory effect allosterically by preventing the hybrid domain swingout in 1 (Luo et al., 2004) , and the current study con firmed the lack of direct occlusion of the fibronectinbinding surface by this antibody. The crystal structure also revealed that the binding of SG/19 not only restricted the global domain ori entation but also fixed the local conformation of the A domain by directly binding to the lower half of the 1 helix. In 3, this helix moves inward to push the 7 helix during the transition to the highaffinity state, resulting in the approach of ADMIDAS toward MIDAS (Fig. 4 B; Xiong et al., 2002; Luo and Springer, 2006) . We predict that a similar conformational change can take place in 1 during the ligand binding, as suggested earlier by culture supernatants by an immunoaffinity chromatography using anticoiled-coil antibody 2H11 (Chang et al., 1994) followed by a gel filtration on a Superdex 200 HR column (1.6 × 60 cm; GE Healthcare) equilibrated with 20 mM Tris and 150 mM NaCl, pH 7.5 (TBS), containing 1 mM CaCl 2 and 1 mM MgCl 2 . The peak fraction was concentrated to 1 mg/ml and stored at 80°C until used. Removal of the C-terminal coiled-coil clasp and the hexahistidine tag was achieved by treatment with TEV protease at room temperature for 16 h. SG/19 IgG from mouse hybridoma cell culture supernatant was purified using a Protein A column (GE Healthcare). SG/19 Fab fragment was prepared by papain digestion using immobilized papain (Thermo Fisher Scientific). The DNA sequences for the variable region of the SG/19 heavy and light chains were determined as follows: in brief, total RNA was isolated from the hybridoma cells using the SV Total RNA isolation kit (Promega), and the cDNA was amplified by RT-PCR reaction using the OneStep RT-PCR kit (QIAGEN) with Ig-Primer Sets (EMD). The PCR products were cloned into pDrive vector (QIAGEN) and then sequenced. Sequences have been deposited in GenBank/EMBL/ DDBJ under accession no. HE578877 (for heavy chain) and accession no. HE578878 (for light chain).
Crystallization and data collection Unclasped 51 fragment was incubated with a saturating concentration of SG/19 Fab fragment, and the resultant integrin-Fab complex was purified on a Superdex 200 column equilibrated with 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM CaCl 2 , and 1 mM MgCl 2 . Purified protein was concentrated to 6 mg/ml for crystallization using an Ultrafree-0.5 centrifugal concentrator (10-kD molecular mass cutoff; Millipore). Initial screening for crystallization conditions was performed using Index (Hampton Research). For this screen, a mosquito crystallization robot (TTP LabTech) was used to dispense 200 nanoliters of protein solution mixed in a 1:1 ratio with the reservoir solution. Drops were equilibrated over 100 µl of reservoir solution using the sitting drop vapor diffusion method at 293 K. The initial crystallization condition (0.1 M bis-tris, pH 6.5, and 20% polyethylene glycol monomethyl ether 5000) was further optimized using a 24-well crystallization plate with the hanging drop vapor diffusion method. Each well contained 500 µl of reservoir solution, and the drop volume was a mixture of 0.3 µl of protein solution and 0.3 µl of reservoir solution. The reproducibility of the crystals was greatly improved by the addition of microseed crystals in the crystallization drop. Diffraction-quality crystals were obtained under a condition of 0.1 M bis-tris, pH 6.5, and 20% polyethylene glycol 8000 at 293 K and grew to dimensions of 100 × 100 × 20 µm within 2 wk. The RGD peptide complex crystals were prepared by soaking the crystals of ligand-free form in 1 mM RGD peptide (NH 2 -GlyArgGlyAspAsnPro-COOH) for 30 min at 293 K.
Before x-ray diffraction experiments, crystals were soaked in reservoir solution containing an additional 20% ethylene glycol and flash cooled in liquid nitrogen. X-ray diffraction datasets for the crystals were collected at 95 K on beamline BL17A at Photon Factory using a wavelength of 1.000 Å and a charge-coupled device detector (Quantum 270; Area Detector Systems Corporation). All datasets were processed and scaled using HKL2000 program suite (Otwinowski and Minor, 1997) .
Structure determination and refinement Initial phase determination was performed by molecular replacement using the program MOLREP (Vagin and Teplyakov, 1997) in the CCP4 program suite. The atomic coordinates of the V3 headpiece (Protein Data Bank accession no. 1L5G) and a murine Fab fragment (Protein Data Bank accession no. 1FGN) were used as search models. The orientation and position of -propeller and thigh domain of 5 subunit and A domain of 1 subunit were initially determined. Subsequently, the positions of variable and constant regions of SG/19 Fab fragment were determined. After several cycles of rigid body refinement by the program REFMAC5 (Murshudov et al., 1997) of the CCP4 program suite, the hybrid domain of 1 subunit could be introduced. Model reconstruction was conducted manually with Coot (Emsley and Cowtan, 2004 ). Crystallographic refinement was performed using the program REFMAC5. As a final check on the model, the stereochemical quality was assessed using the program Molprobity (Lovell et al., 2003) . The final models included the following residues: chain A, 1-600; chain B, 6-29 and 43-445; chain C, 1-512, 518-553, and 560-600; chain D, 5-33 and 43-445; chains E and L, 1-219; and chains F and H, 1-218. Data collection and refinement statistics are summarized in Table 1 . All figures were prepared using PyMOL (DeLano Scientific). Atomic coordinates and structural factors have been deposited in the Protein Data Bank under accession no. 3VI3 (unliganded form) and accession no. 3VI4 (RGD peptide complex).
this metal remains somewhat controversial. Mould et al. (2003a) reported that mutation to ADMIDAS in 51 resulted in a diminished ligandbinding ability. They also observed that the mutant became resistant to the artificial activation by an activat ing antibody, TS2/16, and that activation by Mn 2+ no longer exposed the activation epitope. From these observations, the authors concluded that ADMIDAS was critical in maintaining the active conformation of the receptor. On the other hand, Chen et al. (2003) found that a similar mutation in the ADMIDAS of 47 integrin expressed on the cell surface canceled the de fault lowaffinity state of the integrin, resulting in the overall upregulation of cell adhesion. This led to a proposal that the ADMIDAS represents a negative regulatory site for integrin function. These seemingly contradicting results can be recon ciled if we take a view that the function of ADMIDAS is to physically link the change in the ligand-MIDAS bond to the change elsewhere in the molecule, particularly the hybrid domain via the 1 helix. Thus, the mutation of ADMIDAS resi dues would decouple the conformational relay in both direc tions, resulting in either activation or deactivation of a particular integrin depending on its default affinity state.
There has been a debate over how the integrin conforma tion and the ligand binding are mutually related. Particularly, the hypothesis that a global conformational change (i.e., a switchbladelike integrin extension) is linked to the local con formational upregulation of the ligandbinding MIDAS has been challenged by Adair et al. (2005) , who observed a com pact (bent) conformer of V3 upon fibronectin binding. This discrepancy can be reconciled with the current structure because it unequivocally showed that even an integrin permanently main tained in a lowaffinity conformation by an inhibitory antibody is capable of ligand binding via the highaffinity form of MIDAS. In addition, we have recently found, using EM, that 1 inte grins do not assume acutely bent conformation under the non activating condition (unpublished data). It is possible that the ligand binding and the overall integrin conformation are less tightly coupled than originally thought, especially in 1 inte grins. Nevertheless, the existence of local conformational cou pling between the ligandbinding pocket and the 1 helix-hybrid domain region in  subunit is supported by an overwhelming number of studies (Mould et al., 2002; Xiong et al., 2002; Xiao et al., 2004; Zhu et al., 2010) . Exactly how this conformational relay system, exerted mainly by ADMIDAS, contributes to the insideout and outsidein integrin signal transduction needs to be explored in more detail using structural as well as cell bio logical analysis.
Materials and methods
Preparation of the 51 integrin headpiece and SG/19 Fab fragment The expression construct for the 5 subunit contained residues 1-623 followed by a 30-residue ACID-Cys peptide, and the construct for 1 contained residues 1-445 followed by a Tobacco etch virus (TEV) protease recognition sequence, a 30-residue BASE-Cys peptide, and a hexahistidine tag. When combined, the C-terminal ACID-Cys and BASE-Cys segments form an intersubunit disulfide-bridged -helical coiled-coil (called clasp) that can be released by a treatment with TEV protease (Takagi et al., 2002) . These constructs were cotransfected into CHO Lec 3.2.8.1 cells to establish stable cell lines. Recombinant integrins were purified from the MD simulation All atom MD simulations of the A domain of 51 were performed using the CHARMM (c35b2) software package (Brooks et al., 1983) . The CHARMM27 force field parameter (MacKerell et al., 1998) with CMAP correction (MacKerell et al., 2004) was used for the protein and the RGD ligand. The parameter developed by Babu and Lim (1999) was used for Ca 2+ and Mg 2+ . The TIP3P model (Jorgensen et al., 1983) was used for water molecules. The crystal structure of the ligand-free form was used as the starting structure without modification, except for the manual placement of the RGD peptide at location defined by the RGD complex structure when calculating the effect of ligand binding. We used a generalized solvent boundary potential (GSBP; Im et al., 2001 ) and focused dynamics of protein around the metal-binding sites. To set up the system for use with GSBP, the region surrounding three metal-binding sites (LIMBS, MIDAS, and ADMIDAS) was solvated using a preequilibrated solvent sphere with a radius of 20 Å centered on Ser132 of 1. Solvent molecules within 2.6 Å of any nonhydrogen atom of the protein were removed. The 10-picosecond equilibration and the aforementioned solvation process were iteratively repeated until the number of newly added solvent molecules became less than five. The final equilibrated structure was used for 10 independent MD runs. We assigned different initial velocity for each run. MD simulations were performed using Langevin dynamics at 300 K with a friction constant corresponding to a relaxation time of 5 picoseconds 1 applied to the nonhydrogen atoms. The geometry of the water was kept fixed using SHAKE (Ryckaert et al., 1977) . A time step of 2 femtoseconds was used. After 500 picoseconds of equilibration (100 picoseconds of solvent relaxation, 200 picoseconds of protein relaxation with the fixed MIDAS coordination structure, and another 200 picoseconds of full relaxation), we performed 40 nanoseconds of MD simulation for each run. The trajectories without showing the Ca 2+ dissociation were used for all analysis, except for analyzing the dissociation itself.
Fibronectin-binding assays
All recombinant fibronectin fragments encompassing the 7th to 10th Fn3 repeats (Fn7-10) were produced using a bacterial expression system as previously described (Takagi et al., 2003) . In brief, a segment corresponding to residues 1,142-1,509 of human fibronectin with one Cys residue added after residue 1,509 was cloned into pET11c vector (EMD) and expressed in Escherichia coli. Protein was purified from bacterial lysates by anion-exchange chromatography on a HiTrap Q column (GE Healthcare) and biotinylated via the sulfhydryl group of the Cys with polyethylene oxide-maleimide-activated biotin (Thermo Fisher Scientific) according to the manufacturer's recommendation. Synergy site mutants with triple (R1374A/ P1376A/R1379A) or single (R1379A) mutations were prepared by QuikChange mutagenesis. To produce full-length 51 ectodomain fragments, 293T cells were transiently transfected with vectors encoding 5 (residues 1-954) and 1 (residues 1-708) with the C-terminal coiled-coil, and the covalently linked heterodimeric proteins carrying 5 mutations (E81A, E124A, or D154A) or the WT sequence were purified from the culture supernatants. Solid-phase binding assay was performed as follows: solutions of purified full-length 51 ectodomains (5 µg/ml in TBS containing 1 mM CaCl 2 and 1 mM MgCl 2 ) were used to coat 96-well microtiter plates (MaxiSorp; Thermo Fisher Scientific) by an overnight incubation at 4°C. Coating with BSA was used to determine the background values of unspecific binding. After a 1-h blocking step (1% BSA in TBS), varying concentrations of biotinylated Fn7-10 were incubated in the presence of 1 mM Mn 2+ for 3 h at room temperature. After washing, bound Fn7-10 was chromogenically detected by peroxidase-streptavidin conjugate and substrate. For the surface plasmon resonance binding experiments, biotinylated Fn7-10 was directly captured on streptavidin-conjugated Sensor Chip SA (GE Healthcare). Various 51 integrin heterodimers were used as analytes at a flow rate of 20 µl/min. Between each run, bound integrin was completely stripped off from the ligand by regeneration of the surface with 50 mM NaOH containing 20 mM EDTA.
Online supplemental material
Figs. S1 and S2 show the structural superpositions between two 51-SG/19 complexes contained in the asymmetric unit (Fig. S1 ) and between the ligandfree and RGD-bound complexes (Fig. S2 ). Fig. S3 shows the detailed depictions of metal coordination geometries in the MIDAS and ADMIDAS of 1 and 3 chains. Fig. S4 shows the S134(O)-Mg 2+ distance tracings for all trajectories during the MD simulations. Videos 1 and 4 present rocking videos showing the overall structure of the 51 headpiece-SG/19 Fab complex in the absence (Video 1) and presence (Video 4) of RGD ligand. Videos 2 and 3 present rocking videos of the 2Fo-Fc electron density map of the ligandfree (Video 2) and RGD-bound (Video 3) integrin near the MIDAS region.
